Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 2/20 | 0.33 |
| ▸ | FEN1 | P39748 | 2/20 | 0.33 |
| ▸ | HRH2 | P25021 | 1/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.31 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.30 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.30 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.30 |
| ▸ | PIM1 | P11309 | 1/20 | 0.30 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.30 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13353984 | 0.80 | TDO2 (0.37) | ALOX5APFEN1HRH2HRH3 | |
| SCHEMBL24890645 | 0.80 | TDO2 (0.37) | ALOX5APFEN1HRH2HRH3 | |
| SCHEMBL30987664 | 0.78 | USP7 (0.36) | PIM1PIM3PIM2 | |
| SCHEMBL17375384 | 0.78 | USP7 (0.36) | PIM1PIM3PIM2 | |
| SCHEMBL28651824 | 0.77 | PIK3CG (0.41) | ALOX5APFEN1 | |
| SCHEMBL14926882 | 0.76 | USP7 (0.31) | — | |
| SCHEMBL24248254 | 0.70 | ATR (0.36) | ALOX5APFEN1 | |
| SCHEMBL24890965 | 0.64 | ATR (0.48) | ALOX5APFEN1HRH2HRH3 | |
| SCHEMBL24890808 | 0.64 | ATR (0.48) | ALOX5APFEN1HRH2HRH3 | |
| SCHEMBL14652767 | 0.64 | NOS3 (0.33) | HRH2HRH3MCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113527231-A | Synthetic method of heterocyclic ring substituted coelenterazine compound | 深圳华大生命科学研究院 | 2021-10-22 | — | — | CN | disclosed |